Recent Finacing
Recent Raise
Octagon Therapeutics is a preclinical biopharmaceutical company using an MGH-derived drug-discovery platform to identify metabolic-pathway-targeting small-molecule antibiotics against ESKAPE Gram-negative pathogens, with R&D in Cambridge, MA.